Login / Signup
Exceptional Response to Pembrolizumab and Trastuzumab in a Heavily Pretreated Patient With HER2-Positive TMB-H and MSI-H Metastatic Breast Cancer.
Allen Li
Shaun Goodyear
Cristina Fuss
Zahi I Mitri
Published in:
JCO precision oncology (2022)
Keyphrases
</>
metastatic breast cancer
case report
advanced non small cell lung cancer